YOLFTbeta
00

Jiuzhitang Co Ltd

000989 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

8.23CNY-0.10 (-1.20%)

Price History

Full chart

Market Stats

Previous Close8.33
Open8.30
Day Range8.21 – 8.34
52-Week Range7.40 – 10.49
Volume7.90M
Market Cap7.46B
P/E (TTM)22.33
Forward P/E14.35
EPS0.39
Dividend Yield3.51%
Beta0.14
50-Day Avg9.01
200-Day Avg8.91

About

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription drug product systems, Jiaxi Ganxian granules, and Chidan Tuihuang granules for liver diseases. The company also provides over-the-counter (OTC) drugs comprising blood-tonifying, cardiovascular and cerebrovascular, urinary system, pediatric, gynecologic, bone and muscles, respiratory system, dermatologic, nervous system, ENT, and digestive system products, and stem cell and other drugs. Jiuzhitang Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Li Zhen Guo
  • Employees3.67K
  • HeadquartersChaoyang Sports Center, Beijing, China, 100026, China
  • Websitehttps://www.hnjzt.com

Leadership

  • Mr. Li Zhen GuoVice Chairman & General Manager · b. 1960
  • Mr. Lubao ZhouCFO & Head of Accounting · b. 1978
  • Mr. Chenxiao HanBoard Secretary · b. 1986
  • Mr. Yansong GaoDeputy General Manager · b. 1982
  • Ms. Chunfeng LiuDeputy General Manager · b. 1963
  • Mr. Yongsheng WuDeputy General Manager · b. 1984
  • Mr. Liangbin ZhangDeputy General Manager · b. 1981

Financials

Income Statement

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue246.04M310.12M329.54M455.84M709.69M905.13M1.02B1.02B1.05B946.53M1.02B1.10B1.11B1.12B1.14B609.64M704.35M797.60M871.51M2.67B3.84B3.16B3.18B3.56B3.78B3.03B2.96B2.37B2.21B
Growth (%)-+26.05%+6.26%+38.33%+55.69%+27.54%+12.53%+0.38%+2.73%-9.88%+8.20%+7.52%+0.74%+1.19%+1.23%-46.35%+15.54%+13.24%+9.27%+206.80%+43.49%-17.58%+0.68%+11.81%+6.31%-19.84%-2.38%-19.91%-6.94%
Cost of Revenue132.78M194.41M192.69M296.52M458.03M567.05M618.18M623.88M646.24M534.25M506.00M485.29M448.64M477.32M533.59M118.33M160.02M172.51M186.90M1.08B1.20B1.20B1.23B1.42B1.56B1.26B1.18B985.07M953.65M
Gross Profit113.26M115.71M136.85M159.32M251.66M338.08M400.39M398.51M404.06M412.29M518.11M615.80M660.57M645.07M616.22M491.30M544.33M625.09M684.61M1.60B2.63B1.96B1.95B2.14B2.22B1.77B1.79B1.39B1.25B
Gross Margin46.03%37.31%41.53%34.95%35.46%37.35%39.31%38.98%38.47%43.56%50.59%55.93%59.55%57.47%54.23%80.59%77.28%78.37%78.55%59.70%68.61%61.90%61.28%60.19%58.77%58.51%60.31%58.46%56.79%
Operating Expense91.19M89.96M98.63M115.42M194.52M270.67M309.10M293.41M374.43M356.67M420.57M508.11M488.70M482.18M410.28M116.79M118.59M154.67M140.98M858.95M1.80B1.57B1.68B1.79B1.86B1.32B1.44B1.13B1.01B
Operating Income22.07M25.75M38.22M43.90M57.13M67.41M91.28M105.10M29.64M55.62M97.54M107.69M171.87M162.90M205.94M374.51M425.74M470.42M543.64M737.25M834.30M382.99M268.64M351.46M366.50M454.12M349.82M251.33M247.21M
Operating Margin8.97%8.30%11.60%9.63%8.05%7.45%8.96%10.28%2.82%5.88%9.52%9.78%15.50%14.51%18.13%61.43%60.44%58.98%62.38%27.57%21.75%12.11%8.44%9.87%9.69%14.97%11.81%10.60%11.20%
EBITDA34.31M36.09M49.48M62.47M83.68M96.27M127.87M143.63M42.72M74.19M187.32M232.09M224.52M226.70M268.49M5.29M15.13M518.30M596.40M866.77M948.83M502.39M366.24M462.20M479.41M579.05M473.88M366.83M373.59M
EBITDA Margin13.94%11.64%15.02%13.70%11.79%10.64%12.55%14.05%4.07%7.84%18.29%21.08%20.24%20.20%23.63%0.87%2.15%64.98%68.43%32.42%24.73%15.89%11.50%12.98%12.67%19.09%16.00%15.47%16.93%
Net Income18.88M22.17M31.47M37.92M52.37M62.92M82.09M105.79M23.57M44.56M127.81M199.89M148.32M162.69M201.78M322.59M364.01M403.32M471.03M651.81M721.42M336.48M192.15M272.31M270.70M357.99M297.41M216.20M222.60M
Net Income Margin7.67%7.15%9.55%8.32%7.38%6.95%8.06%10.35%2.24%4.71%12.48%18.15%13.37%14.50%17.76%52.91%51.68%50.57%54.05%24.38%18.80%10.64%6.04%7.65%7.15%11.80%10.04%9.12%10.09%
R&D-------------20.44M18.24M15.30M16.13M25.13M26.73M54.68M92.94M85.43M101.92M113.42M117.78M142.37M145.26M146.20M130.63M
R&D as % of Total Revenue-------------1.82%1.61%2.51%2.29%3.15%3.07%2.05%2.42%2.70%3.20%3.19%3.11%4.69%4.91%6.17%5.92%
Interest Expense12.22M10.92M11.49M11.53M8.82M8.65M5.40M1.11M82.43K629.76K8.22M26.16M13.59M6.00K6.00K494.79K6.00K502.73K47.63K1.42M2.31M1.92M2.20M2.93M9.28M4.97M4.16M2.79M1.56M
Interest Expense % of Total Revenue4.97%3.52%3.49%2.53%1.24%0.96%0.53%0.11%0.01%0.07%0.80%2.38%1.22%0.00%0.00%0.08%0.00%0.06%0.01%0.05%0.06%0.06%0.07%0.08%0.25%0.16%0.14%0.12%0.07%

Balance Sheet

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets283.88M325.82M376.36M811.60M871.96M1.02B1.34B1.34B1.30B1.37B1.44B1.55B1.55B1.74B1.80B1.84B1.89B2.15B4.47B4.80B5.87B5.25B4.90B5.07B5.27B5.24B5.33B5.21B5.44B
Total Liabilities190.95M225.42M218.40M315.10M327.70M479.18M230.81M185.43M206.32M361.17M263.47M315.38M287.00M358.85M348.02M373.51M348.77M540.15M682.97M660.41M1.37B937.28M912.97M1.15B1.30B1.26B1.38B1.26B1.29B
Total Equity92.53M99.95M157.51M496.07M501.80M510.02M1.08B1.14B1.09B1.01B1.18B1.23B1.26B1.38B1.45B1.47B1.54B1.61B3.79B4.14B4.50B4.30B3.99B3.92B3.97B3.99B3.95B3.75B3.72B
Cash23.67M35.41M57.48M411.74M232.16M227.51M510.31M509.74M446.50M605.57M486.53M582.44M787.66M826.46M747.90M610.31M498.12M465.42M1.27B1.56B839.67M546.06M297.43M794.78M808.08M1.09B672.71M592.88M406.21M
Total Debt106.14M142.48M141.16M154.90M161.30M256.28M47.88M6.55M553.46K150.56M565.46K571.46K577.46K583.46K589.46K595.46K601.46K607.46K613.46K619.46K---101.93M106.04M86.60M123.84M51.50M136.40M
Net Debt82.47M107.07M83.68M-256.84M-70.86M28.77M-462.43M-503.20M-445.94M-455.01M-485.96M-581.87M-787.08M-825.87M-747.32M-609.71M-497.52M-464.81M-1.27B-1.56B-839.67M-546.06M-297.43M-692.85M-702.04M-1.00B-548.87M-541.38M-269.81M

Cash Flow

Currency: CNY2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow54.87M81.05M94.55M81.89M100.54M58.08M135.96M81.45M131.21M220.92M185.79M139.72M87.78M28.45M118.59M339.03M612.38M152.00M425.86M851.29M609.56M365.91M499.13M121.40M198.96M438.30M
Investing Cash Flow-48.01M-194.45M-124.25M-19.19M-15.11M-38.67M-2.00M-17.53M39.11M103.33M-25.60M-98.58M-106.33M-80.89M27.77M466.10M-30.62M-530.49M-195.96M-573.52M123.02M62.73M83.97M-301.84M93.96M-473.69M
Financing Cash Flow347.41M-66.18M25.05M220.10M-85.99M-82.66M25.11M-182.96M-74.40M-119.04M-122.04M-119.04M-119.04M-59.76M-179.07M-100.00M-302.43M-346.66M-533.77M-499.11M-234.72M-415.14M-302.74M-236.35M-372.86M-213.72M
Capital Expenditure36.05M177.75M149.32M28.57M32.83M20.71M75.82M33.65M50.64M33.31M29.63M114.37M165.36M249.04M94.53M48.27M72.75M123.64M141.93M151.05M80.91M207.32M96.83M72.84M72.22M39.95M
Free Cash Flow18.82M-96.70M-54.77M53.32M67.71M37.37M60.14M47.80M80.57M187.61M156.16M25.36M-77.58M-220.58M24.06M290.75M539.63M28.35M283.93M700.24M528.65M158.60M402.30M35.79M126.73M398.35M
Dividends Paid10.66M59.18M42.15M62.09M47.76M79.06M52.91M32.96M74.40M119.04M119.04M119.04M119.04M59.52M178.56M100.00M302.38M347.74M347.74M335.98M335.98M342.38M342.38M342.38M338.61M253.88M
FCF to OCF34.29%-119.30%-57.93%65.11%67.35%64.34%44.23%58.68%61.41%84.92%84.05%18.15%-88.39%-775.22%20.29%85.76%88.12%18.65%66.67%82.26%86.73%43.34%80.60%29.49%63.70%90.88%
Dividend Paid to FCF56.68%-61.20%-76.97%116.45%70.53%211.56%87.99%68.96%92.34%63.45%76.23%469.50%-153.44%-26.98%742.17%34.39%56.04%1226.49%122.47%47.98%63.55%215.88%85.10%956.51%267.18%63.73%

Earnings

Report DateMar 31, 2009Jun 30, 2009Oct 21, 2009Dec 31, 2009Apr 9, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Mar 31, 2016Jun 30, 2016Oct 26, 2016Dec 31, 2016Apr 26, 2017Jul 27, 2017Oct 26, 2017Dec 31, 2017Apr 19, 2018Jul 30, 2018Oct 30, 2018Dec 31, 2018Apr 29, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 30, 2020Aug 15, 2020Oct 24, 2020Mar 19, 2021Apr 23, 2021Aug 14, 2021Oct 25, 2021Dec 31, 2021Apr 22, 2022Aug 12, 2022Sep 30, 2022Dec 31, 2022Apr 28, 2023Aug 7, 2023Oct 25, 2023Dec 31, 2023Apr 24, 2024Jun 30, 2024Sep 30, 2024Mar 27, 2025May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--0.11-0.13----------------------------------------------------------------
EPS Actual0.100.120.090.120.110.120.090.160.090.090.130.280.080.080.090.070.110.080.370.090.120.090.130.380.120.110.050.150.200.180.220.150.260.180.230.160.210.01-0.010.100.110.010.000.110.130.040.050.130.130.060.000.140.290.03-0.040.190.100.050.010.170.070.04-0.030.140.030.010.080.190.10
Surprise---18.18%--15.38%----------------------------------------------------------------
Timing--After-hours-After-hours------------------------Pre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-market------After-hours----After-hoursPre-market--Pre-marketPre-marketPre-market-Pre-market--Pre-marketAfter-hours-----

Key Statistics & Ratios

Market Cap7.46B
Enterprise Value6.39B
Trailing P/E22.33
Forward P/E14.35
PEG Ratio0.00
Price / Sales2.87
Price / Book2.02
EPS0.39
Book Value4.35
Revenue (TTM)2.60B
Gross Profit (TTM)1.55B
EBITDA556.28M
Profit Margin12.67%
Operating Margin19.36%
Return on Equity10.86%
Return on Assets5.15%
Shares Outstanding855.94M
Shares Float448.72M
Beta0.14
Dividend Yield3.51%
Dividend Rate0.30
Payout Ratio77.16%

Dividends

20261×
0.30May 14, 2026
20251×
0.30May 8, 2025
20241×
0.40May 28, 2024
20231×
0.40Jun 6, 2023
20221×
0.40Jun 1, 2022
20211×
0.40Apr 20, 2021
20201×
0.40Jun 1, 2020
20191×
0.40Jun 11, 2019
20181×
0.40Jun 13, 2018
20171×
0.40Jun 7, 2017
20161×
0.35May 27, 2016
20141×
0.52May 28, 2014
20131×
0.17Jun 27, 2013
20121×
0.35May 31, 2012
20111×
0.35Jun 3, 2011
20101×
0.35Jun 21, 2010
20091×
0.35Jun 3, 2009
20081×
0.22May 29, 2008
20071×
0.07Apr 5, 2007
20061×
0.29May 22, 2006
20051×
0.22Apr 21, 2005
20041×
0.12May 12, 2004
20031×
0.20May 21, 2003
20021×
0.12May 23, 2002

Stock Splits

  • May 27, 201611.5:10
  • May 29, 20081.2:1
  • May 12, 200412:10
  • Oct 18, 20021.3:1